Discontinued — last reported Q3 '25
Non-Current Liabilities
Long-Term Debt
Boston Scientific Long-Term Debt increased by 0.1% to $11.60B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.6%, from $10.89B to $11.60B. Over 4 years (FY 2020 to FY 2024), Long-Term Debt shows an upward trend with a 4.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2015
Last reportedQ3 2025Nov 3, 2025
How to read this metric
An increase indicates higher leverage and interest expense, while a decrease suggests debt repayment or deleveraging.
Detailed definition
This represents the total value of debt obligations, such as bonds or loans, that are due for repayment beyond the curre...
Peer comparison
Varies significantly by industry; capital-intensive sectors like healthcare often carry higher long-term debt.
Metric ID:
long_term_debtHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.11B | $9.09B | $9.07B | $9.31B | $8.97B | $8.58B | $8.94B | $9.01B | $9.05B | $8.90B | $9.10B | $10.62B | $10.57B | $10.89B | $10.75B | $11.31B | $11.59B | $11.60B |
| QoQ Change | — | -0.3% | -0.2% | +2.6% | -3.6% | -4.3% | +4.1% | +0.8% | +0.5% | -1.7% | +2.3% | +16.7% | -0.5% | +3.0% | -1.3% | +5.2% | +2.5% | +0.1% |
| YoY Change | — | — | — | — | -1.5% | -5.5% | -1.4% | -3.2% | +0.9% | +3.7% | +1.9% | +17.9% | +16.8% | +22.3% | +18.1% | +6.5% | +9.6% | +6.6% |
Range$8.58B – $11.60B
CAGR+5.9%
Avg YoY Growth+6.6%
Median YoY Growth+5.1%
Current Streak3 quarters growth
Long-Term Debt at Other Companies
Frequently Asked Questions
- What is Boston Scientific's long-term debt?
- Boston Scientific (BSX) reported long-term debt of $11.60B in Q3 2025.
- How has Boston Scientific's long-term debt changed year-over-year?
- Boston Scientific's long-term debt increased by 6.6% year-over-year, from $10.89B to $11.60B.
- What is the long-term trend for Boston Scientific's long-term debt?
- Over 4 years (2020 to 2024), Boston Scientific's long-term debt has grown at a 4.1% compound annual growth rate (CAGR), from $9.14B to $10.75B.
- What does long-term debt mean?
- The total amount of debt that is not due for repayment within the next year.